Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

BioProduction by SEKISUIBioProduction by SEKISUI
VS
AmgenAmgen
BioProduction by SEKISUI

BioProduction by SEKISUI

N/A

Last Update: 21/03/2026

View Profile
751/1000Fair

BioProduction by SEKISUI describes SEKISUI’s contract service offering as a fermentation focused CDMO with expertise in proteins and downstream purification. Our production site in the UK has been a leader in the manufacturing of high-quality proteins and specialty bioc...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Amgen

Amgen

One Amgen Center Drive, Thousand Oaks, CA, US, 91320

Last Update: 14/06/2026

View Profile
Between 800 and 849
http://www.amgen.com
820/1000Good

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human gene...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:39,570
Subsidiaries:4
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
BioProduction by SEKISUI

BioProduction by SEKISUI

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Amgen

Amgen

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for BioProduction by SEKISUI in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Amgen in 2026.

Incidents

Incident History - BioProduction by SEKISUI (X = Date, Y = Severity)

BioProduction by SEKISUI cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Amgen (X = Date, Y = Severity)

Amgen cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
BioProduction by SEKISUI

BioProduction by SEKISUI

Incidents
No explicit notable incidents reported.
Amgen

Amgen

Incidents
🔒 Incident : Breach
AMG552072825

FAQ

Between BioProduction by SEKISUI company and Amgen company, which one has the best AI Cybersecurity Score ?
Between BioProduction by SEKISUI company and Amgen company, which one has experienced more cyber incidents in the past ?
Between BioProduction by SEKISUI company and Amgen company, which one has experienced more cyber incidents this year ?
Between BioProduction by SEKISUI company and Amgen company, which one has experienced at least one ransomware attack ?
Between BioProduction by SEKISUI company and Amgen company, which one has experienced at least one data breach ?
Between BioProduction by SEKISUI company and Amgen company, which one has experienced at least one targeted cyberattack ?
Between BioProduction by SEKISUI company and Amgen company, which one has experienced at least one vulnerability ?
Between BioProduction by SEKISUI company and Amgen company, which one holds the most compliance certifications ?
Between BioProduction by SEKISUI company and Amgen company, which one holds the fewest compliance certifications ?
Between BioProduction by SEKISUI company and Amgen company, which one has the most subsidiaries ?
Between BioProduction by SEKISUI company and Amgen company, which one has the largest number of employees ?
Between BioProduction by SEKISUI and Amgen, which company holds both SOC 2 Type 1 certifications ?
Between BioProduction by SEKISUI and Amgen, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - BioProduction by SEKISUI or Amgen ?
Which company is PCI DSS compliant - BioProduction by SEKISUI or Amgen ?
Between BioProduction by SEKISUI and Amgen, which company complies with HIPAA regulations for healthcare data ?
Between BioProduction by SEKISUI and Amgen, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-58523
SUMMARY

Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-14617
SUMMARY

A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 3.1)
CVSS2
Base Score: 2.1
Complexity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
CVSS3
Base Score: 3.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 1.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.6
CVE-2026-58597
SUMMARY

Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-58524
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-58522
SUMMARY

Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
2.5